Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCRB00541
2016-12-22
Prospective
2016.457
NA
NA
NA
Not Applicable
cosy cheung
office 4, 1 Floor, Block F (special block), Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, N.T., Hong Kong
26323199
cosycheung@cuhk.edu.hk
research nurse
Hong Kong
Dr. CHUNG Pui Wah, Jacqueline
1/F, Special Block (Block E), Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, N.T., Hong Kong
26321537
jacquelinechung@cuhk.edu.hk
Assistant Professor
Hong Kong
Incidence of intrauterine adhesion after manual vacuum aspiration for first-trimester miscarriages
Incidence of intrauterine adhesion after manual vacuum aspiration for first-trimester miscarriages
手動真空抽吸術治療早孕期流產後宮腔粘連的發生率
Incidence of intrauterine adhesion after manual vacuum aspiration for first-trimester miscarriages
Hong Kong
Yes
2016-09-29
Joint CUHK-NTEC Clinical Research Ethics Committee
2016.457
intrauterine adhesion
first trimester miscarriage
manual vacuum aspiration
Procedure
MVA is inexpensive, portable, simple to use, convenient, avoids the use of electricity but more importantly can be performed without general anesthesia. The procedure is performed in an outpatient setting with simple oral analgesics or conscious sedation given beforehand. MVA has a high efficacy with similar success rates as electric vacuum aspiration.3 The use of ultrasound guidance during MVA may reduce the discomfort during the introduction, shorten the procedure and ensure that the miscarriage process is complete.
Intrauterine adhesion (IUA) or Asherman’s syndrome is a possible complication after uterine surgery, especially after sharp curettage curette for miscarriages as it destroys the endometrial stratum basalis. IUA can be asymptomatic or it can present with menstrual disturbance like amenorrhea or hypoamenorrhea, dysmenorrhea or with recurrent miscarriages or infertility problems. The presence of intrauterine adhesion may affect future fertility as it may affect the implantation of the embryo. Moreover, it increases the rate of further miscarriages, may lead to abnormal placentation, fetal growth restriction, preterm delivery and post-partum haemorrhage.4 Early detection of IUA is important as early treatment can prevent further complications. The gold standard for the diagnosis of IUA is hysteroscopy.
All women who had MVA or surgical evacuation performed for first trimester delayed or incomplete miscarriage will be invited to participate the study by our research assistant. For those who agree to join the study, an outpatient hysteroscopy will be performed within 3-6 months from their MVA or evacuation procedure by a designated team of experienced gynaecologist. Outpatient hysteroscopy is the gold standard of diagnosing IUA and it is a very common gynaecological procedure in our everyday practice. The hysteroscopy will be performed within day 10 of their last menstrual period and the patient will be advised to use barrier contraception before the procedure. A pregnancy test will be performed before the procedure and any recent coitus recorded.
The outpatient hysteroscopy will be performed using a 2.9mm rigid diagnostic hysteroscopy (Karl Storz, Germany) under aseptic technique and the endometrial cavity will be visualized and assessed systematically. Normal saline will be used for uterine distension. Cervical dilatation is not required and no analgesia will be prescribed. The patient will be discharged from the hospital approximately one hour after the procedure.
The presence of any intrauterine adhesion, the status of bilateral ostias and endometrial cavity and endometrium will berecorded. The severity will be ascertained according to the classification of the American Fertility Society for IUA. 8 If IUA is present, it will be removed during the outpatient procedure.
this is not a drug trial
this is not a drug trial
this is not a drug trial
outpatient hysteroscopy will be performed within 3-6 months from their MVA or evacuation procedure
In a recent meta-analysis, the incidence of intrauterine adhesion is reported to be 18.5% after traditional surgical evacuation.5-6 Up to now, there is limited data to evaluate the incidence of intrauterine adhesion after manual vacuum aspiration for early miscarriages. 7 In this study, we wish to examine the incidence of intrauterine adhesion after manual vacuum aspiration performed for first trimester miscarriages and compared it with that after traditional method of evacuation of uterine cavity by curettage.
this is not a drug trial
this is not a drug trial
this is not a drug trial
outpatient hysteroscopy will be performed within 3-6 months from their MVA or evacuation procedure
All women presenting to our unit with MVA or traditional surgical curettage performed for first-trimester miscarriage or incomplete miscarriage will be invited to join the study.
Women with MVA or surgical curettage performed done for miscarriage gestation > 12 weeks
Women known to have intrauterine adhesion
Subjects with known congenital uterine anomalies or multiple uterine fibroids distorting cavity
Women with known cervical stenosis
Women with recent pelvic inflammatory disease
18
45
Female
Observational
Not Applicable
Not Applicable
Open label
Not Applicable
Other
This is not a drug trial
2016-12-28
110
Not Yet Recruiting
1. To determine the incidence of intrauterine adhesion or Asherman’s syndrome after MVA performed for first trimester delayed or or incomplete miscarriage and compare it with the incidence of traditional surgical evacuation
For those who agree to join the study, an outpatient hysteroscopy will be performed within 3-6 months from their MVA or evacuation procedure by a designated team of experienced gynaecologist.
at the time of outpatient hysteroscopy
2. To evaluate the patient’s acceptability of the procedure and rate of surgical failure with retained products of conception.
participants will fill in questionnaires
at the day of outpatient hysteroscopy
2023-08-07
|
|
|
|
|
---|---|---|---|---|
No documents yet. |